
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical liquid containing magnesium chloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products contain magnesium chloride only in combination with other active ingredients, in injection, solution and irrigant forms.
Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Magnesium chloride is a magnesium salt used to supply the mineral magnesium, which compounding pharmacies prepare in oral forms by prescription.
Magnesium chloride is a water-soluble salt that supplies magnesium, a mineral that acts as a cofactor in more than 300 enzyme systems and supports muscle and nerve function, heart rhythm, blood sugar control and bone. NIH notes the chloride form tends to be absorbed better than the oxide or sulfate. DailyMed lists a prescription magnesium chloride injection for magnesium deficiency that is marketed without FDA approval (Mylan Institutional); magnesium chloride is also an ingredient in Hospira's TPN Electrolytes, approved under an NDA as an additive to intravenous nutrition, and in supplements such as Mag64. StatPearls lists sustained-release oral magnesium chloride as an option for repleting low magnesium in patients without symptoms. A prescriber might order it compounded as an oral preparation in a strength or form not otherwise available. Compounded preparations are not FDA-approved and require a prescription.
No boxed warning applies to magnesium chloride. The most common problems with high supplemental doses are diarrhea, nausea and stomach cramps. Very high intakes can cause magnesium toxicity, with low blood pressure, flushing, muscle weakness, trouble breathing, irregular heartbeat and, rarely, cardiac arrest; the risk is much higher with reduced kidney function, so tell your prescriber about kidney disease. Magnesium can bind tetracycline and quinolone antibiotics and oral bisphosphonates such as alendronate, so doses need to be spaced apart. Loop and thiazide diuretics raise magnesium loss, potassium-sparing diuretics lower it, and long-term proton pump inhibitor use can cause low magnesium. LactMed has no magnesium chloride entry; its magnesium sulfate entry notes that intravenous magnesium raises milk levels only slightly and infants absorb little by mouth. Talk to your prescriber or pharmacist before combining magnesium with other medicines or if side effects occur.
Less than one percent of body magnesium is in serum, and the kidneys regulate balance by adjusting urinary excretion. ODS notes better bioavailability for the chloride, citrate, lactate and aspartate salts than for oxide or sulfate, though the supporting studies are small. Labeled use: TPN Electrolytes (Hospira) contains magnesium chloride with sodium, potassium and calcium salts and is indicated as an additive to concentrated dextrose and amino acid solutions for adults receiving central venous nutrition; it must be diluted and carries an aluminum toxicity warning. StatPearls describes oral sustained-release magnesium chloride for asymptomatic, nonhospitalized patients with hypomagnesemia and parenteral magnesium sulfate for symptomatic or unstable patients; no FDA-approved oral magnesium chloride drug product is listed on DailyMed, and Mag64 is labeled as a dietary supplement. In patients with significantly reduced kidney function, StatPearls advises dose reduction and close monitoring because of hypermagnesemia risk. Monitor serum magnesium, potassium, calcium and renal function, and separate dosing from tetracyclines, quinolones and bisphosphonates. Dosing is per prescriber. Magnesium chloride is not a controlled substance.
Wash your hands. Apply the amount on your label to clean, dry skin using the applicator provided or a cotton swab. Let it dry before covering. Use an accurate measuring device if your label gives a volume. Keep it away from the eyes and avoid open flame if the solution contains alcohol. Wash your hands afterward.
Topical solutions are aqueous or alcohol based. Under USP <795>, a preserved aqueous solution usually carries a beyond-use date of up to 35 days; an unpreserved one 14 days refrigerated; a nonaqueous solution may carry up to 180 days. Keep the bottle tightly closed at room temperature, away from heat and flame, out of reach of children, and discard after the beyond-use date on your label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.